Hearing loss company Acousia Therapeutics to present key learnings and data from lead development programs at US and European meetings in August and September
Acousia Therapeutics GmbH to share key learnings and data from its lead candidate development programs — clinical stage ACOU085 and late preclinical stage ACOU082 —